diagnostic-accuracy

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 69/100

   Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis

   ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-12-23 · Biomarkers

   Our review summarizes the diagnostic accuracy of plasma and cerebrospinal fluid (CSF) phosphorylated tau 217 (p-tau217) in detecting amyloid and tau pathology on positron emission tomography (PET).

   • Diagnosis
   • Biomarkers
2. 57/100

   Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

   ✓ Peer-reviewed alzhub usefulness score 57 out of 100. International journal of molecular sciences · 2024-04-23 · Biomarkers

   We compared the clinical and analytical performance of Alzheimer's disease (AD) plasma biomarkers measured using the single-molecule array (Simoa) and Lumipulse platforms.

   • Biomarkers
   • Diagnosis
3. 64/100

   Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform

   ✓ Peer-reviewed alzhub usefulness score 64 out of 100. The journal of prevention of Alzheimer's disease · 2024-01-01 · Biomarkers

   Plasma p-tau217 measured using the Lumipulse platform shows promise as an accurate biomarker of preclinical AD pathology.

   • Biomarkers
   • Early Stage
   • Diagnosis
4. 71/100

   Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework

   ✓ Peer-reviewed alzhub usefulness score 71 out of 100. CNS neuroscience & therapeutics · 2023-07-12 · Biomarkers

   Our findings suggest that plasma, CSF, and neuroimaging biomarkers differ considerably within the ATN framework; the most accurate target biomarkers for diagnosing AD were the CSF-A, neuroimaging-T, and neuroimaging-N within each ATN modality.

   • Biomarkers
   • Brain Scans
   • Diagnosis
5. 55/100

   Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest

   ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Frontiers in aging neuroscience · 2021-03-04 · Biomarkers

   Manual ELISA assays are the most commonly used methods for quantification of biomarkers; however, they often show inter- and intra-laboratory variability that limits their wide use.

   • Biomarkers
   • Diagnosis
6. 47/100

   Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases

   ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neuropathology and applied neurobiology · 2019-07-19 · Biomarkers

   Plasma t-PrP is elevated in prion diseases regardless of aetiology.

   • Biomarkers
   • Diagnosis
   • Genetics
7. 50/100

   Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

   ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018-02-03 · Biomarkers

   Increased NFL levels are a common feature in neurodegenerative dementias.

   • Biomarkers
   • Diagnosis
   • Genetics

All topic tags with their study counts